ocadusertib (LY3871801) / Eli Lilly, Rigel  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ocadusertib (LY3871801) / Eli Lilly
NCT05222399: A Study of LY3871801 in Healthy Participants

Completed
1
15
RoW
LY3871801
Eli Lilly and Company
Healthy
03/22
03/22
NCT05602675: A Drug Interaction Study of LY3871801 in Healthy Participants

Completed
1
39
US
LY3871801, Methotrexate, Warfarin, Dextromethorphan, Midazolam, Repaglinide
Eli Lilly and Company
Healthy
03/23
03/23
NCT05960851: A Study of LY3871801 in Healthy Asian and Non-Asian Participants

Completed
1
32
US
LY3871801, Placebo
Eli Lilly and Company
Healthy
10/23
10/23
NCT06049108: A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants

Completed
1
8
US
[14C]-LY3871801
Eli Lilly and Company
Healthy
11/23
11/23

Download Options